Skip to main content

Brief Provocation of Anger Adversely Affects Endothelial Health

Medically reviewed by Carmen Pope, BPharm. Last updated on May 1, 2024.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, May 1, 2024 -- A brief provocation of anger has an adverse effect on endothelial cell health, according to a study published online May 1 in the Journal of the American Heart Association.

Daichi Shimbo, M.D., from the Columbia University Irving Medical Center in New York City, and colleagues examined the acute effects of provoked anger on endothelial cell health among 280 apparently healthy adults. Participants were randomly assigned to an eight-minute anger recall task, a depressed mood recall task, an anxiety recall task, or an emotionally neutral condition.

The researchers observed a group-by-time interaction for the anger versus neutral condition on the change in reactive hyperemia index (RHI) from baseline to 40 minutes, with changes of 0.20 and 0.50 in RHI in the anger and neutral conditions, respectively. The anxiety versus neutral condition group-by-time interaction approached but did not reach statistical significance for the change in RHI, while the sadness versus neutral condition group-by-time interaction was not statistically significant. No consistent significant group-by-time interactions were seen for the anger, anxiety, and sadness versus neutral conditions on endothelial cell-derived microparticles and endothelial progenitor cells from baseline to 40 minutes.

"An implication of these findings is that the contribution of a biological mechanism that increases cardiovascular disease risk may differ across core negative emotions," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM

FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...

DNA Methylation-Based Epigenetic Age Mediates Link Between LE8 Score, CVD

WEDNESDAY, May 29, 2024 -- The associations between Life's Essential 8 (LE8) and cardiovascular health are mediated by DNA methylation-based epigenetic age, according to a study...

Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular Disease

TUESDAY, May 28, 2024 -- Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.